Irbesartan

NDC 33342-047 · Macleods Pharmaceuticals Limited

Generic nameIrbesartan

Dosage formTABLET

RouteORAL

Active ingredient(s)IRBESARTAN

Strength75 mg/1

Pharmacologic classAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]

Marketing categoryANDA

Packages

33342-047-07 — 30 TABLET in 1 BOTTLE (33342-047-07)

33342-047-10 — 90 TABLET in 1 BOTTLE (33342-047-10)

33342-047-12 — 10 BLISTER PACK in 1 CARTON (33342-047-12) / 10 TABLET in 1 BLISTER PACK

33342-047-15 — 500 TABLET in 1 BOTTLE (33342-047-15)

33342-047-68 — 13600 TABLET in 1 POUCH (33342-047-68)

FDA lists these products with the same active ingredient.

29300-213 — Irbesartan, 29300-214 — Irbesartan, 29300-215 — Irbesartan and Hydrochlorothiazide, 29300-216 — Irbesartan and Hydrochlorothiazide, 31722-160 — Irbesartan, 31722-161 — Irbesartan, 31722-162 — Irbesartan, 31722-729 — Irbesartan, 31722-730 — Irbesartan, 31722-731 — Irbesartan, 33342-048 — Irbesartan, 33342-049 — Irbesartan, 33342-057 — Irbesartan and Hydrochlorothiazide, 33342-058 — Irbesartan and Hydrochlorothiazide, 42291-940 — IRBESARTAN, 42291-941 — IRBESARTAN, 42291-942 — IRBESARTAN, 42658-121 — IRBESARTAN, 42658-122 — IRBESARTAN, 42658-123 — IRBESARTAN, +95 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.